Somatorel 5mg Injection

Somatorel 5mg Injection is a prescription based medicine with active ingredient Somatropin. It is the same as the main type of naturally occurring human growth hormone. It is used in the treatment of children with growth failure due to inadequate secretion of endogenous growth hormone (GH). It is also used to treat short stature in adults. This injection should be administered into the skin by a doctor or experienced nurse. Don't self- administer the injection?

• Growth failure due to growth hormone deficiency

Every medicine has some side effects that typically manage on their own as your body gets used to the medicine, but some people may experience severe side effects rarely. In that case, the patient should contact the doctor immediately.
Some common side effects of Somatorel 5mg Injection include:

• Rash
• Injection site reactions (pain, swelling, redness)
• Headache

• Somatorel 5mg is available in injection form and is advised to be taken as per the doctor's prescription. It should be administered by a doctor or experienced nurse under strict medical supervision. Taking this injection in the wrong way may give you severe side effects.
• In case of overdose, contact your healthcare provider or doctor and they will provide you with medical attention. Missing or overdosing will impact the overall health of the patients and may also have side effects. So, it is always advisable to follow the prescription of the doctor strictly.
  
  

Somatorel 5mg Injection is a prescription based medicine with active ingredient Somatropin. This injection has similarities in structure with natural human growth hormone, which is essential to muscle and bone growth. Also, it helps in the proper proportion of muscle and fat tissue development.

• Deal, C. L., Steelman, J., Vlachopapadopoulou, E., Stawerska, R., Silverman, L. A., Phillip, M., ... & Miller, B. S. (2022). Efficacy and safety of weekly somatrogon vs daily somatropin in children with growth hormone deficiency: a phase 3 study. The Journal of Clinical Endocrinology & Metabolism, 107(7), e2717-e2728. https://pubmed.ncbi.nlm.nih.gov/35405011/
• Svensson, J., & Johannson, G. (2003). Long-term efficacy and safety of somatropin for adult growth hormone deficiency. Treatments in Endocrinology, 2(2), 109-120. https://pubmed.ncbi.nlm.nih.gov/15871547/
• Horikawa, R., Tanaka, T., Hasegawa, Y., Yorifuji, T., Ng, D., Rosenfeld, R. G., ... & Castellanos, O. (2022). Efficacy and safety of once-weekly somatrogon compared with once-daily somatropin (Genotropin®) in Japanese children with pediatric growth hormone deficiency: results from a randomized phase 3 study. Hormone research in paediatrics, 95(3), 275-285. https://pubmed.ncbi.nlm.nih.gov/35417909/
• Pawlikowska-Haddal, A. (2013). Growth hormone therapy with norditropin (somatropin) in growth hormone deficiency. Expert opinion on biological therapy, 13(6), 927-932. https://pubmed.ncbi.nlm.nih.gov/23662811/
• Mehta, A., & Hindmarsh, P. C. (2002). The use of somatropin (recombinant growth hormone) in children of short stature. Pediatric Drugs, 4(1), 37-47. https://ouci.dntb.gov.ua/en/works/4LbK1j39/